Home > Healthcare > Pharmaceuticals > Finished Drug Form > Lisinopril Market
Lisinopril Market Size
- Report ID: GMI9455
- Published Date: May 2024
- Report Format: PDF
Lisinopril Market Size
Lisinopril Market size was valued at around USD 1.5 billion in 2023 and is estimated to grow at 4.8% CAGR from 2024 to 2032. Lisinopril is a medication primarily used to treat high blood pressure and heart failure. It belongs to a class of drugs called angiotensin-converting enzyme (ACE) inhibitors. Lisinopril works by relaxing blood vessels helps to lower blood pressure and improve blood flow to the heart. It's typically taken orally once daily
The growing prevalence of cardiovascular diseases is a significant driver for lisinopril market. For instance, according to the National Library of Medicine, in January 2023, coronary artery disease (CAD) accounted for approximately 6,10,000 deaths annually (estimated 1 in 4 deaths) and is the leading cause of mortality in the U.S. Also, it is the third leading cause of mortality worldwide and is associated with 17.8 million deaths annually. Thus, this underscores the critical importance of medications such as lisinopril in managing cardiovascular conditions and reducing mortality rates.
Furthermore, increasing aging population, growing awareness and screening programs, and innovations in drug delivery are contributing factors stimulating the growth of the market.
| Report Attribute | Details |
|---|---|
| Base Year: | 2023 |
| Lisinopril Market Size in 2023: | USD 1.5 Billion |
| Forecast Period: | 2024 – 2032 |
| Forecast Period 2024 – 2032 CAGR: | 4.8% |
| 2024 – 2032 Value Projection: | USD 2.3 Billion |
| Historical Data for: | 2021 – 2023 |
| No. of Pages: | 290 |
| Tables, Charts & Figures: | 341 |
| Segments covered: | Dosage, Dosage Strength, Patient Age Group, Application, Distribution Channel, and Region |
| Growth Drivers: |
|
| Pitfalls & Challenges: |
|
Frequently Asked Questions (FAQ) :
Lisinopril Market Scope
